These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1381298)

  • 41. Autoreactive cytotoxicity in HIV-infected individuals.
    Israël-Biet D; Venet A; Beldjord K; Andrieu JM; Even P
    Clin Exp Immunol; 1990 Jul; 81(1):18-24. PubMed ID: 1974178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
    Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
    Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
    Rayner AA; Grimm EA; Lotze MT; Wilson DJ; Rosenberg SA
    J Natl Cancer Inst; 1985 Jul; 75(1):67-75. PubMed ID: 2989604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.
    Takahashi K; Nakamura T; Koyanagi M; Kato K; Hashimoto Y; Yagita H; Okumura K
    J Immunol; 1990 Dec; 145(12):4371-9. PubMed ID: 1979586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA; Lotzová E
    Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells.
    Lobo PI; Patel HC
    Immunology; 1994 Oct; 83(2):240-4. PubMed ID: 7835941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms.
    Bean P; Mazumder A
    Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural specificity of MHC-unrestricted recognition of HCMV-infected target cells by human CD56+NK and LAK cells.
    Steinmassl M; Anderer FA
    Scand J Immunol; 1994 Dec; 40(6):665-8. PubMed ID: 7527935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
    Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4.
    Drobyski WR; LeFever AV; Truitt RL
    Exp Hematol; 1991 Oct; 19(9):950-7. PubMed ID: 1716592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report.
    Warzynski MJ; Barbour SD; Winkler-Pickett RT; Ortaldo JR
    Cytometry; 1994 Dec; 18(4):231-6. PubMed ID: 7534677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ability of lymphokine-activated killer cells to lyse mycobacteria-infected cells.
    Chiplunkar SV; Deshmukh MA; Kode JA; Gangal SG; Deo MG
    Acta Leprol; 1997; 10(4):203-8. PubMed ID: 9447253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR; Sassenfeld HM; Widmer MB
    J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells.
    Mason LH; Mathieson BJ; Ortaldo JR
    J Immunol; 1990 Jul; 145(2):751-9. PubMed ID: 2365999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
    Holladay FP; Heitz T; Wood GW
    J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphokine-activated killing by human intestinal lymphocytes.
    Ebert EC; Roberts AI
    Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM; Radcliff G; Waite R; LeFevre J; Poulik MD
    Cytometry; 1991; 12(7):666-76. PubMed ID: 1782834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.